The hormone replacement therapy field has established protocols for administering therapies like progesterone or estrogen replacement, and patients are aware of potential adverse outcomes, but this is not the case for BPC, where the substance, its dissolution, or other factors may cause problems 10m20s
44 An open-label, uncontrolled trial in 51 patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) found improvements in 34 patients after 3 months of supplementation with hydroxo-B12, 10 000 mcg twice per week as nasal drops
For 10 mg vials, 3-5 mL works well
Unlike hormones that stay in the body for a long time, peptides bind to the receptor of cells, cause a chemical reaction, then go away
12 Third, RILT causes the release of nitric oxide, a potent vasodilator, leading to increased blood flow and tissue repair